Sconce, M D

Intervention with 7,8-dihydroxyflavone blocks further striatal terminal loss and restores motor deficits in a progressive mouse model of Parkinson's disease. [electronic resource] - Neuroscience Apr 2015 - 454-71 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.

1873-7544

10.1016/j.neuroscience.2014.12.080 doi


Animals
Antiparkinson Agents--pharmacology
Calcium-Binding Proteins
Corpus Striatum--drug effects
Flavones--pharmacology
Forelimb--drug effects
Intracellular Signaling Peptides and Proteins--metabolism
MPTP Poisoning--drug therapy
Male
Mice, Inbred C57BL
Mitogen-Activated Protein Kinase 1--metabolism
Mitogen-Activated Protein Kinase 3--metabolism
Motor Activity--drug effects
Phosphorylation--drug effects
Random Allocation
Receptor, trkB--metabolism
Stathmin
Substantia Nigra--drug effects
Tyrosine 3-Monooxygenase--metabolism